Enrofloxacin monohydrochloride
CAS: 93106-59-3
Ref. 3D-TDA10659
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 25g | Discontinued | ||
| 50g | Discontinued | ||
| 250mg | Discontinued | ||
| 2500mg | Discontinued |
Product Information
Name:
Enrofloxacin monohydrochloride
Synonyms:
- 3-Quinolinecarboxylicacid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-,monohydrochloride (9CI)
Description:
Enrofloxacin monohydrochloride is a medicinal product that acts as a protein kinase inhibitor. It has been shown to inhibit the growth of cancer cells, including leukemia cells, by inducing apoptosis and cell cycle arrest. Enrofloxacin monohydrochloride has been tested in Chinese hamster ovary cells and found to be effective in inhibiting tumor growth. This drug is excreted mainly through urine and has been shown to have anticancer properties due to its ability to inhibit protein kinases involved in cancer cell proliferation. Enrofloxacin monohydrochloride is a promising therapeutic option for the treatment of various types of cancer in humans.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
395.9 g/mol
Formula:
C19H23ClFN3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
